Bioxytran (OTCMKTS:BIXT) to Release Cancer Preprint Revealing Potential Immunotherapy EnhancementOn January 10, 2025, Bioxytran Inc., a clinical-stage biotechnology company focused on developing oral and intravenous drugs for various conditions, anno
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Bioxytran’s 8K...
Amylyx Pharmaceuticals Enters Underwriting Agreement for Public Offering
On January 10, 2025, Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) announced its entry into an underwriting agreement with Leerink Partners LLC for the issuance and sale...
Greggs (LON:GRG) Shares Down 14.5% – What’s Next?
Greggs plc (LON:GRG – Get Free Report) dropped 14.5% on Thursday . The stock traded as low as GBX 2,210 ($26.98) and last traded at...
Duke Energy Co. (DUK) to Issue Quarterly Dividend of $1.05 on March 17th
Duke Energy Co. (NYSE:DUK – Get Free Report) declared a quarterly dividend on Thursday, January 9th,RTT News reports. Shareholders of record on Friday, February 14th...
Greggs (LON:GRG) Trading Down 14.6% – Should You Sell?
Greggs plc (LON:GRG – Get Free Report) traded down 14.6% on Thursday . The company traded as low as GBX 2,238 ($27.33) and last traded...
PepsiCo (NASDAQ:PEP) Trading 0.8% Higher – Should You Buy?
PepsiCo, Inc. (NASDAQ:PEP – Get Free Report)’s stock price shot up 0.8% during mid-day trading on Thursday . The stock traded as high as $146.67...